70 Year Old Male Patient with History of Intermittent Hematuria of 5 Month Duration

Abstract

Papillary carcinoma (PC) is the second most common type of renal cell carcinoma (RCC). PC has specific imaging and clinical features that may help in differentiation from clear cell RCC. At contrast material–enhanced CT and MRI, PC enhances less than other RCC in all phases of contrast-enhanced imaging.The classification of renal cell carcinoma into subtypes is important as it has association with outcome of disease. Results have shown that renal cell carcinoma is not a single disease but, rather, a group of several disease entities [1]. According to the First International Workshop on Renal Cell Carcinoma held by the World Health Organization, renal cell carcinoma can be classified into conventional (i.e., clear cell) renal carcinoma, papillary renal carcinoma, chromophobe renal carcinoma, collecting duct renal carcinoma, and unclassified renal carcinoma [1]. Current findings reported in the literature suggest that the tumor is often hypo vascular on computed tomography (CT) and MRI [1,2], and is hypo intense on T2 weighted imaging [2]. Papillary renal cell carcinoma (RCC) is the second most common form of RCC, after clear cell RCC, accounting for 10-15% of cases [3]. In comparison with clear cell RCCs, papillary RCCs in general have less aggressive features, including being both smaller in size and lower in stage at presentation [3]. Morphology: The T2 weighted tumor signal was homogeneous in 57% of cases, slightly heterogeneous in 9% and heterogeneous in 34%. Eighty-nine percent of tumors were hypo intense compared to the normal renal parenchyma on T2 weighted images, 9% were hyper intense and 2% were intense. For masses imaged with MRI, the presence or absence of hemosider in was determined, defined as the subjective identification of loss of signal intensity on longer-TE in-phase images relative to opposed-phase T1-weighted dual-echo gradient-recalled echo images. Relative signal intensity in comparison with the normal renal parenchyma (i.e., hypo intense, is intense, hyper intense) was also recorded on unenhanced T1- weighted, unenhanced T2-weighted, and contrast-enhanced T1-weighted images. In addition, the presence or absence of enhancement was determined subjectively on subtraction images [3].

Authors and Affiliations

Sushila B Ladumor

Keywords

Related Articles

Newly Diagnosed With Prostate Cancer? - A Mentor/Patient Discussion

Please recognize that I am not a Medical Doctor. Rather, as a medical detective, I have been an avid student researching and studying prostate cancer as a survivor and continuing patient since 1992. I have dedicated my r...

Effect of Cane on the Knee and Thorax Biomechanics in the Early Postoperative Period Following Total Knee Arthroplasty

Background: Although total knee arthroplasty (TKA) reliably reduces pain and improves knee function, several months are needed for the damaged quadriceps muscles to recover to preoperative strength. Patients with weak mu...

Posters Presentation on Breast Feeding, Mother Cancer Awareness, Mother and Child Health, Mother Healthy Food and Mother Mental Health

The Idea is to Present and Collect Number of Five Posters on the following Topics men-tioned below in one Article to be Prepared and published for Research Purposes.

Small Brain Vessels Disease

Small vessel disease is a disorder of cerebral micro vessels that causes hyperintensities of the white matter and other frequent alterations, such as small subcortical infarcts and recent lacunae, which can be seen in br...

The Smile Aesthetics and its Implications in Social Prosthetic Rehabilitations: A Case Report

The aim of this study is to individualize the correlative aspects between the type of smile , the degree of visibility of the teeth and the way in which the chosen therapeutic solution, in accordance with the particulari...

Download PDF file
  • EP ID EP570654
  • DOI 10.26717/BJSTR.2017.01.000281
  • Views 205
  • Downloads 0

How To Cite

Sushila B Ladumor (2017). 70 Year Old Male Patient with History of Intermittent Hematuria of 5 Month Duration. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(3), 705-707. https://europub.co.uk/articles/-A-570654